Accelerate Diagnostics Inc (FRA:1A80)
€ 1.13 0.09 (8.65%) Market Cap: 28.23 Mil Enterprise Value: 51.27 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 41/100

Accelerate Diagnostics Inc at JPMorgan Healthcare Conference Transcript

Jan 13, 2022 / 02:45PM GMT
Release Date Price: €35.2 (-9.28%)
Tycho W. Peterson
JPMorgan Chase & Co, Research Division - Senior Analyst

All right. Good morning, everybody. I'm Tycho Peterson from the life science team. It's my pleasure to introduce our next company this morning, Accelerate Diagnostics. Just a quick reminder, you could submit questions through the website. And with that, let me turn it over to Jack.

Jack Phillips
Accelerate Diagnostics, Inc. - CEO, President & Director

Great, Tycho. Thank you, and thanks to JPMorgan for putting on another great conference this week. We've had some fantastic meetings, and we really appreciate it. For those that are dialing in, I know you'll be advancing the slides on your own. So I'll do my best. You should be able to keep up with me just fine, but I'll do my best to call out a few slides as I go through the presentation this morning. First off, please take note of our safe harbor statement. Thank you.

Today, I plan to cover a few important topics. While we continue to increase our market penetration in 2021, it was just another challenging year

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot